(Q46799056)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16281075%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Improved treatment results for childhood acute myeloid leukemia in Taiwan (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16281075%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

childhood acute myeloid leukemia

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16281075%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Liang DC

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16281075%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Chan TT

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16281075%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Lin KH

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16281075%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Lin DT

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16281075%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Chen SH

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16281075%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Liu HC

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16281075%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Lin MT

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16281075%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Lee MT

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16281075%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Shu SG

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16281075%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Chang TK

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16281075%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Chen JS

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16281075%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Hsiao CC

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16281075%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Hung IJ

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16281075%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Hsieh YL

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16281075%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Chen RL

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16281075%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Cheng SN

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16281075%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Chang WH

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16281075%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Lee CH

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16281075%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Lin KS

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16281075%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16281075%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16281075%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16281075%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16281075%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

136-141

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16281075%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403979

9 January 2020

exact match

0 references

cites work

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

Impact of high-dose cytarabine and asparaginase intensification on childhood acute myeloid leukemia: a report from the Childrens Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

Impact of addition of maintenance therapy to intensive induction and consolidation chemotherapy for childhood acute myeloblastic leukemia: results of a prospective randomized trial, LAME 89/91. Leucámie Aiqüe Myéloïde Enfant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

Results of consecutive trials for children newly diagnosed with acute myeloid leukemia from the Australian and New Zealand Children's Cancer Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome: results of NOPHO-AML trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

The World Health Organization (WHO) classification of the myeloid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

Treatment strategy and long-term results in pediatric patients treated in two consecutive AML-GATLA trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

Long-term results in children with AML: NOPHO-AML Study Group--report of three consecutive trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

Twenty years of Polish experience with three consecutive protocols for treatment of childhood acute myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

High-dose chemotherapy in adult acute myeloid leukemia: rationale and results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

Effects of three new anthracyclines and doxorubicin on the rat isolated heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

Idarubicin cardiotoxicity: a retrospective study in acute myeloid leukemia and myelodysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

Combination of mitoxantrone and etoposide in refractory acute myelogenous leukemia--an active and well-tolerated regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

Attempted recruitment of leukemic myeloblasts to proliferative activity by sequential drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

Cytosine arabinoside in the treatment of acute myeloid leukemia: the role and place of high-dose regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

7 January 2021

Molecular analysis of fusion transcripts in childhood acute myeloid leukemia in Taiwan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

7 January 2021

Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

7 January 2021

Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocols.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

7 January 2021

Long-term results of children with acute myeloid leukemia: a report of three consecutive Phase III trials by the Children's Cancer Group: CCG 251, CCG 213 and CCG 2891.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

7 January 2021

Acute myelogenous leukemia in Chile PINDA protocols 87 and 92 results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

7 January 2021

Treatment strategy and results in children treated on three Dutch Childhood Oncology Group acute myeloid leukemia trials.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

7 January 2021

Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

7 January 2021

Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit--multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

7 January 2021

Successive clinical trials for childhood acute myeloid leukemia at St Jude Children's Research Hospital, from 1980 to 2000.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

7 January 2021

Causes of death--other than progressive leukemia--in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

7 January 2021

Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

7 January 2021

Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

7 January 2021

Saving the children--improving childhood cancer treatment in developing countries

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403979

7 January 2021